United Therapeutics Corporation Reports First Quarter 2019 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/24/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Needham Starts NeoVolta (NEOV) at Buy
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- NextEra to discuss paying about $76 per share for Dominion, Bloomberg News reports
- Campbell Soup (CPB) Declares $0.39 Quarterly Dividend; 7.7% Yield
- KKR launches Helix with over $10 billion to build AI infrastructure
United Therapeutics (UTHR) Tops Q1 EPS by 80c, Revenues Beat
May 1, 2019 6:09 AM EDTUnited Therapeutics (NASDAQ: UTHR) reported Q1 EPS of $3.58, $0.80 better than the analyst estimate of $2.78. Revenue for the quarter came in at $362.6 million versus the consensus estimate of $335.43 million.
"I'm very pleased to report that last quarter we helped more pulmonary arterial hypertension (PAH) patients with our... More
